The Latest Articles from Streetwise Reports


Aurora Cannabis Shares Catch Fire on Positive Q3/20 Financial Results

  ()
Shares of Aurora Cannabis traded 60% higher after the company reported an 18% rise in net revenue, which included a 24% increase in consumer sales versus to the prior quarter. read more >

Allogene Therapeutics Shares Climb 30% on Phase 1 Relapsed/Refractory NHL Study Data

  ()
Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial. read more >
News Update

Biotech Expands Antibody Research Across Multiple Neurodegenerative Diseases and Covid-19

News Update
  ()
ProMIS Neurosciences advances its various antibody programs related to neurodegenerative diseases and viral infections such as Covid-19. read more >
News Update

Biotech Advances Accurate SARS CoV-2 Antibodies Detection Test

News Update
  ()
Testing and validation of ProMIS Neurosciences' antibody targets will be conducted over the coming weeks. read more >
News Update

Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech

Research Report
  ()
The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report. read more >

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

  ()
Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. read more >
News Update

Pharmaceutical Firm Gains Ethics Approval for Phase 2 Human IPF and Chronic Cough Trial

News Update
  ()
Algernon Pharmaceuticals received ethics approval in Australia for a Phase 2 human clinical study of NP-120 (Ifenprodil) for use in treatment of idiopathic pulmonary fibrosis and chronic cough. read more >

Protagonist's Shares Nearly Double After Reporting Q1 Earnings and Positive Phase 2 Trial Results

  ()
Shares of Protagonist Therapeutics traded higher and reached a new 52-week high price after the company released Q1/20 financial results and positive data from its Phase 2 study of PTG-300 in patients with polycythemia vera, a type of blood cancer. read more >
News Update

Canadian Firm Partners for US Sales of Its Telehealth Platform

News Update
  ()
This arrangement will bolster the use of CloudMD Software & Services' software in the United States. read more >

California Biotech Partners for Manufacture of COVID-19 Vaccine Candidate

Research Report
  ()
Arcturus Therapeutics Holdings' arrangement is explained and commented on in an H.C. Wainwright & Co. report. read more >
News Update

Biotech Develops Antagonists for Protein Tied to Neurodegenerative Diseases

News Update
  ()
ProMIS Neurosciences' antagonists prevent dysfunctional protein aggregation. read more >

Horizon Therapeutics Shares Rise 15% on Strong Q1 Results and Raised F/Y Sales Guidance

  ()
Shares of Horizon Therapeutics traded higher setting a new 52-week high price after the company reported a 27% y-o-y increase in net sales for Q1/20 and raised FY/20 net sales guidance. read more >

Building a Better Covid-19 Antibody Test

  ()
ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. read more >
News Update

Firm Partners with Canada's Largest Western Grocery Chain and Leading Community Pharmacy to Pilot In-Store Virtual Patient Care

News Update
  ()
CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms. read more >

Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing

  ()
Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals. read more >
News Update

Telehealth Platform Added to Vendor Lists of Leading Medical Associations

News Update
  ()
Use of CloudMD Software & Services' health solution is seeing significant growth. read more >
News Update

Firm Creates Novel Intrabodies for ALS and Other Neurodegenerative Diseases

News Update
  ()
ProMIS Neurosciences reported it has generated novel intrabodies that are highly selective for misfolded forms of TAR DNA-binding protein 43 implicated in several neurologic disorders. read more >

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm

  ()
Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. read more >

Seattle Genetics Shares Trade Higher on Q1/20 Earnings and 22% Growth in ADCETRIS Sales

  ()
Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEV™ in its first full quarter of sales. read more >
News Update

Biotech Cleared for Phase 2b/3 Trial of NMDA Receptor Antagonist for COVID-19 Patients in Canada

News Update
  ()
Algernon Pharmaceuticals reported it received approval from Health Canada for a Phase 2b/3 multinational clinical study of Ifenprodil in COVID-19 patients to prevent progression to intubation and mechanical ventilation. read more >
News Update

Mobile Health Solutions Firm Welcomes 8 New Texas Clients to Its Telemedicine Platform

News Update
  ()
Reliq Health Technologies reported that it has signed contracts to add eight new customers in Texas including an oncology practice that will be using its new iUGO Care Principal Care Management module. read more >
News Update

US Counties to Use Tech Firm's Software for COVID-19 Contact Tracing

News Update
  ()
Demand has been taking off for HealthSpace Data Systems' platform released two weeks ago. read more >

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

  ()
Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. read more >

With Contact Tracing Key to Reopening the Economy, New Cloud Platform Attracting High-Profile Users

  ()
As contact tracing moves to center stage as a key to reopening the economy, HealthSpace releases a scalable cloud-based system that is rapidly being adopted, including by the state of Hawaii. read more >

Why These 2 Investment Professionals Say This Telemedicine Company Is One of Their Top Picks

  ()
As the coronavirus pandemic has accelerated the move to telemedicine, two investment professionals are following CloudMD, a small cap rapidly expanding in Canada. read more >
Showing Results: 26 to 50 of 216 Prev Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts